Senzime Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 50

Employees

  • Stock Symbol
  • SEZI

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $0.63
  • (As of Tuesday Closing)

Senzime General Information

Description

Senzime AB, a medical technology company, develops, manufactures, and markets patient monitoring systems for monitoring patients. Its solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease healthcare costs. Its product includes TetraGraph and TetraSens, ExSpiron, TetraSens Pediatric, and TetraConnect. Its geographical segments include Sweden, the United States, Europe/Oceania, and Asia.

Contact Information

Website
www.senzime.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Monitoring Equipment
Stock Exchange
STO
Corporate Office
  • Ulls vag 41
  • 756 51 Uppsala
  • Sweden
+46 0000000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Senzime Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.63 $0.68 $0.24 - $0.82 $75.7M 120M 186K -$0.17

Senzime Financials Summary

In Thousands,
USD
TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 60,513 67,791 146,577 174,709
Revenue 2,765 1,383 1,279 1,013
EBITDA (11,230) (11,669) (8,526) (4,009)
Net Income (12,977) (13,081) (9,565) (5,146)
Total Assets 33,497 30,932 19,296 31,560
Total Debt 1,080 1,250 181 292
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Senzime Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Senzime‘s full profile, request access.

Request a free trial

Senzime Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Senzime AB, a medical technology company, develops, manufactures, and markets patient monitoring systems for monitoring
Monitoring Equipment
Uppsala, Sweden
50 As of 2022
000.00
000000000 000.00

000000

equat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dol
0000000000 000000000
Amsterdam, Netherlands
00000 As of 0000
00000000000

00000

ipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua
0000000000 000000000
Marseille, France
00 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Senzime Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Philips Corporation Amsterdam, Netherlands 00000 00000000000
IDMed Formerly Accelerator/Incubator backed Marseille, France 00 00000 00000000000 00000
Boston Scientific Corporation Marlborough, MA 00000 000.00 000000000 00 000.00
Mindful Scientific Formerly VC-backed Halifax, Canada 0 0000 00000000000 0000
Xavant Corporation Pretoria, South Africa 00
You’re viewing 5 of 10 competitors. Get the full list »

Senzime Patents

Senzime Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3764873-A1 Anesthetizing monitoring system, unit and method therefore Pending 16-Mar-2018 0000000000
US-20210015403-A1 Anesthetizing monitoring system, unit and method therefore Pending 16-Mar-2018 0000000000
EP-3764894-A1 Anesthetizing monitoring system, unit and method therefore Pending 16-Mar-2018 0000000000
US-20210007661-A1 Anesthetizing monitoring system, unit and method therefore Pending 16-Mar-2018 0000000000 0
US-10966641-B2 Microdialysis device comprising attachment sheet Active 04-Sep-2015 A61M25/04 00
To view Senzime’s complete patent history, request access »

Senzime Executive Team (10)

Name Title Board Seat Contact Info
Pia Renaudin Chief Executive Officer
Erik Bergman Chief Financial Officer and Executive Vice President
Slavoljub Grujicic Chief Financial Officer, Finance
Johanna Tulkki Chief Operating Officer and Chief Technology Officer
Anders Jacobson Chief Innovation Officer
You’re viewing 5 of 10 executive team members. Get the full list »

Senzime Board Members (2)

Name Representing Role Since
00000 000000000 Self Board Member 000 0000
000000 000000 Self Chief Executive Officer 000 0000
To view Senzime’s complete board members history, request access »

Senzime Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Senzime Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Senzime‘s full profile, request access.

Request a free trial

Senzime Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Respiratory Motion 01-Jul-2022 0000000000 0000 Monitoring Equipment 000 00000
Acacia Designs 03-May-2016 0000000000 000.00 Monitoring Equipment 0000 0ö00
MD Biomedical 21-Apr-2015 Merger/Acquisition 00000 Other Healthcare Services
To view Senzime’s complete acquisitions history, request access »

Senzime Subsidiaries (1)

Company Name Industry Location Founded
Respiratory Motion Monitoring Equipment Watertown, MA 0000
To view Senzime’s complete subsidiaries history, request access »

Senzime ESG

Risk Overview

Risk Rating

Updated April, 21, 2023

18.2 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,605

Rank

00.00

Percentile

Technology Hardware

Industry

00 of 644

Rank

00.00

Percentile

Electronics Equipment

Subindustry

00 of 131

Rank

00.00

Percentile

To view Senzime’s complete esg history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »